Expert consensus on the perioperative management of co-ablation system therapy of liver tumors.
10.3760/cma.j.cn112138-20240621-00396
- Collective Name:Committee of Ablation Therapy in Oncology;Chinese Anti-Cancer Association;Expert Committee on Ablation Therapy Chinese Society of Clinical Oncology (CSCO)
- Publication Type:Consensus Development Conference
- MeSH:
Humans;
Liver Neoplasms/surgery*;
Perioperative Care;
Consensus;
Catheter Ablation
- From:
Chinese Journal of Internal Medicine
2025;64(2):110-118
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to improve the quality of clinical treatment and nursing care to standardize perioperative management for patients with liver tumors undergoing co-ablation system therapy. The Committee of Ablation Therapy in Oncology, China Anti-Cancer Association; the Expert Committee on Ablation Therapy; Chinese Society of Clinical Oncology (CSCO); and the Committee of Interventional, Perioperative, and Interventional Physician Branch of Chinese Medical Doctors Association organized medical and nursing experts in China. Based on the clinical practice of co-ablation system therapy in China and relevant domestic literature, an expert consensus about perioperative management was developed. The expert consensus included the key points of perioperative management, prevention, and care of complications; discharge guidance; and follow-up management for patients undergoing co-ablation system therapy of liver tumors. The consensus on the perioperative management of co-ablation system therapy for liver tumors has finally been formulated, serving as a reference and application for medical personnel in relevant fields based on hospital and patient conditions in clinical work.
